CalciMedica ( NASDAQ: CALC ) has commenced a public offering of its shares of common stock. All the shares to be sold in the underwritten public offering are to be sold by the company. The company expects to grant a 30-day option to purchase up to an additional 15% of the shares of its common stock sold in the public offering.
Shares of the biopharma firm tumbled over 10% in after hours trading on Wednesday. Source: Press Release More on CalciMedica Seeking Alpha’s Quant Rating on CalciMedica Historical earnings data for CalciMedica Financial information for CalciMedica.
